The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib

Sunil K. Joshi; Janét Pittsenbarger; Vanessa E. Kennedy; Cheryl A.C. Peretz; Alexander E. Perl; Catherine C. Smith; Jeffrey W. Tyner; Brian J. Druker; Elie Traer

doi:10.1002/ajh.27096

The FLT3^N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib

Sunil K. Joshi, Janét Pittsenbarger, Vanessa E. Kennedy, Cheryl A.C. Peretz, Alexander E. Perl, Catherine C. Smith, Jeffrey W. Tyner, Brian J. Druker, Elie Traer

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E364-E368
Journal	American Journal of Hematology
Volume	98
Issue number	12
DOIs	https://doi.org/10.1002/ajh.27096
State	Published - Dec 2023

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.27096

Cite this

@article{1903300ea68549d697cbedda58fd7171,

title = "The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib",

author = "Joshi, {Sunil K.} and Jan{\'e}t Pittsenbarger and Kennedy, {Vanessa E.} and Peretz, {Cheryl A.C.} and Perl, {Alexander E.} and Smith, {Catherine C.} and Tyner, {Jeffrey W.} and Druker, {Brian J.} and Elie Traer",

year = "2023",

month = dec,

doi = "10.1002/ajh.27096",

language = "English (US)",

volume = "98",

pages = "E364--E368",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "12",

}

TY - JOUR

T1 - The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib

AU - Joshi, Sunil K.

AU - Pittsenbarger, Janét

AU - Kennedy, Vanessa E.

AU - Peretz, Cheryl A.C.

AU - Perl, Alexander E.

AU - Smith, Catherine C.

AU - Tyner, Jeffrey W.

AU - Druker, Brian J.

AU - Traer, Elie

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85173773229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85173773229&partnerID=8YFLogxK

U2 - 10.1002/ajh.27096

DO - 10.1002/ajh.27096

M3 - Letter

C2 - 37815132

AN - SCOPUS:85173773229

SN - 0361-8609

VL - 98

SP - E364-E368

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 12

ER -

The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

The FLT3^N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib